{"product_id":"skdiscovery-business-model-canvas","title":"SK Discovery Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSK Discovery Business Model Canvas: Growth Logic, Value \u0026amp; Revenue Drivers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eExplore the strategic framework behind SK Discovery's portfolio approach-this Business Model Canvas outlines how the company builds value across chemicals, life sciences, and materials, supports key subsidiaries, and translates partnerships, capabilities, and cost structure into sustainable growth.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Alliances with Global Energy Majors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSK Discovery, via SK Gas, partners with global energy majors like Shell and BP to secure LPG volumes (covering ~40% of 2024 import needs) and co-invest in hydrogen\/ammonia terminals, sharing capex risks-SK Gas targets net-zero in the energy chain by 2025 and aims to commission 200+ ktpa ammonia receiving capacity with partners, reducing individual capex exposure by an estimated 30-50% per project.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCollaborations with Global Pharmaceutical Research Institutes\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSK Bioscience and SK Plasma partner with global institutes (NIH, CEPI-level consortia, top academic centers) to co-develop vaccines and plasma-derived therapies, sharing proprietary biotech and clinical-trial data; these alliances cut average development time by ~18 months and supported SK Bioscience's 2024-25 pipeline worth an estimated $1.2B in potential peak sales, keeping next-gen biopharma output robust through 2025.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eJoint Ventures in Green Chemical Technology\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSK Chemicals forms joint ventures with specialist tech firms to scale chemical recycling and bio-based polymers, tapping partnerships like its 2024 JV investments that target 100,000 tonnes\/year circular feedstock capacity and aim to cut Scope 3 emissions by ~15% by 2030.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment and Regulatory Body Engagement\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eStrategic cooperation with South Korean and international regulators lets SK Discovery align green energy and biotech projects with Korea's 2050 carbon neutrality goal and MFDS\/EPA safety standards, cutting approval time by up to 30% based on 2023 industry averages.\u003c\/p\u003e\n\u003cp\u003eProactive engagement secures grants and policy support-Korea's Green New Deal has allocated about KRW 73.4 trillion (2020-2025) and similar subsidies can improve project IRRs by 200-600 bps.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eAligns with Korea 2050 carbon neutrality\u003c\/li\u003e\n\u003cli\u003eReduces approval time ~30% (2023 avg)\u003c\/li\u003e\n\u003cli\u003eAccess to KRW 73.4T Green New Deal funds\u003c\/li\u003e\n\u003cli\u003eImproves IRR by 200-600 bps via subsidies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSynergistic Internal Partnerships within SK Group\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSK Discovery taps SK Group's ecosystem to share R\u0026amp;D, supply-chain scale and market intel, enabling cross-affiliate projects that cut costs and speed time-to-market; in 2024 SK Group affiliates reported combined capex of about KRW 18 trillion, driving shared tech rollouts.\u003c\/p\u003e\n\u003cp\u003eThis network powers projects like integrating SK Innovation's battery data with SK Gas's LNG and hydrogen solutions, boosting portfolio EBITDA margins-SK Group reported consolidated EBITDA of KRW 12.5 trillion in 2024-by improving asset utilization and lowering procurement spend.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eShared capex: ~KRW 18 trillion (2024)\u003c\/li\u003e\n\u003cli\u003eConsolidated EBITDA: KRW 12.5 trillion (2024)\u003c\/li\u003e\n\u003cli\u003eCross-industry use: batteries + LNG\/hydrogen\u003c\/li\u003e\n\u003cli\u003eBenefits: lower procurement, higher asset use\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSK Discovery cuts capex, speeds biotech, secures LPG\/hydrogen \u0026amp; taps KRW73.4T Green Fund\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSK Discovery leverages SK Gas, SK Bioscience, SK Chemicals and SK Group ties to secure LPG\/hydrogen imports (~40% of 2024 LPG needs), co-invest 200+ ktpa ammonia capacity, cut project capex ~30-50%, accelerate biotech timelines ~18 months, and access KRW 73.4T Green New Deal funding to lift IRRs 200-600 bps.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e2024 LPG coverage\u003c\/td\u003e\n\u003ctd\u003e~40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAmmonia capacity target\u003c\/td\u003e\n\u003ctd\u003e200+ ktpa\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapex reduction\u003c\/td\u003e\n\u003ctd\u003e30-50%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBiotech time cut\u003c\/td\u003e\n\u003ctd\u003e~18 months\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGreen New Deal\u003c\/td\u003e\n\u003ctd\u003eKRW 73.4T (2020-25)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, pre-built Business Model Canvas for SK Discovery detailing customer segments, channels, value propositions, revenue streams, key activities, resources, partners, cost structure and governance, aligned with real-world operations and investor-ready for presentations and funding discussions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses SK Discovery's pharma and chemical value chain into a single editable canvas for quick strategy review and collaborative updates.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Portfolio Management and Investment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe group continuously evaluates and optimizes its portfolio to maximize long-term shareholder value, targeting high-growth sectors like green materials and advanced biotechnology; in 2024 SK Group allocated about KRW 12 trillion to future growth businesses, with SK Inc. reporting a 22% YoY increase in new energy investments. By rebalancing assets and executing targeted divestments-SK hynix sold non-core stakes raising KRW 3.5 trillion in 2023-the subsidiaries stay agile amid global shifts.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced R and D in Life Sciences and Green Materials\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSK Discovery runs advanced R\u0026amp;D in life sciences and green materials, targeting eco-friendly copolyesters and novel vaccines; R\u0026amp;D spend hit KRW 210 billion in 2024, up 18% year-over-year, to build tech barriers and secure global margins. Continuous innovation in molecular biology and chemical engineering aims to drive revenue growth toward management's 2025 target of KRW 1.2 trillion in core businesses.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eESG Integrated Governance and Oversight\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAs an investment holding, SK Discovery enforces group-wide ESG standards-monitoring chemical-plant emissions (target: 25% CO2 reduction by 2030 from 2020 baseline) and auditing biotech clinical-trial ethics across 12 trials in 2024-strengthening board-level oversight to cut regulatory fines (fell 40% in 2023) and boost appeal to global institutional investors who prefer 70%+ ESG-rated portfolios.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOperational Excellence in Energy Distribution\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSK Discovery runs LPG and hydrogen logistics via affiliates, operating storage terminals and expanding distribution points to industrial and residential customers; in 2024 SK Discovery's energy segment handled ~1.2 million tonnes LPG-equivalent and grew distribution nodes ~8% year-on-year.\u003c\/p\u003e\n\u003cp\u003eEfficient terminal ops and route optimization preserved margins amid 2024 volatility, keeping adjusted EBITDA margin ~11% for the energy unit.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e1.2M tonnes LPG-e (2024)\u003c\/li\u003e\n\u003cli\u003e8% more distribution nodes YoY (2024)\u003c\/li\u003e\n\u003cli\u003e~11% adjusted EBITDA margin (energy, 2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBusiness Development and Global Market Expansion\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpactive pursuit of new markets and international expansion diversifies sk discovery revenue beyond korea by funding market feasibility studies setting up local offices managing foreign trade compliance as chemicals bioscience prioritize scaling in europe north america after reported krw billion trillion. here the quick math: targeting a overseas share within years.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket studies: country-level TAM, CAGR, regulatory gap\u003c\/li\u003e\n\u003cli\u003eLocal presence: offices in EU\/US hubs, M\u0026amp;A or JV options\u003c\/li\u003e\n\u003cli\u003eCompliance: trade, pharma\/chemical regs, IP protection\u003c\/li\u003e\n\u003cli\u003e2024 anchors: SK Bioscience KRW 485B; SK Chemicals KRW 4.1T\u003c\/li\u003e\n\u003cli\u003eGoal: 15-25% revenue from EU\/NA by 2028\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pactive\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSK Discovery pivots to green materials \u0026amp; biotech with KRW12T capex, scaling global reach\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSK Discovery optimizes its portfolio and invests in green materials and biotech (KRW 12T allocated group-wide in 2024; SK Inc. new-energy +22% YoY) while operating LPG\/hydrogen logistics (1.2M tonnes LPG-e, ~11% adj. EBITDA) and scaling overseas (SK Bioscience KRW 485B; SK Chemicals KRW 4.1T; target 15-25% EU\/NA by 2028).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eGroup future growth capex\u003c\/td\u003e\n\u003ctd\u003eKRW 12T\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSK Inc. new-energy change\u003c\/td\u003e\n\u003ctd\u003e+22% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEnergy volume\u003c\/td\u003e\n\u003ctd\u003e1.2M tonnes LPG-e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEnergy adj. EBITDA\u003c\/td\u003e\n\u003ctd\u003e~11%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSK Bioscience revenue\u003c\/td\u003e\n\u003ctd\u003eKRW 485B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSK Chemicals revenue\u003c\/td\u003e\n\u003ctd\u003eKRW 4.1T\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOverseas revenue goal\u003c\/td\u003e\n\u003ctd\u003e15-25% by 2028\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe preview you see is the exact SK Discovery Business Model Canvas document you'll receive after purchase-not a mockup or sample-and upon completing your order you'll download this same professional, fully editable file ready for presentation and use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eesources\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProprietary Intellectual Property and Patents\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSK Discovery holds a broad IP portfolio-over 1,200 patents worldwide as of 2025-covering biotech, vaccine platforms, and specialty chemical formulations; these patents block competitors and underpinned KRW 45 billion in licensing revenue in 2024. Continued R\u0026amp;D spending-KRW 220 billion budgeted for 2025-targets new filings to sustain growth in life sciences and green materials.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eState of the Art Manufacturing and R and D Facilities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSK Discovery operates GMP-certified production plants and R\u0026amp;D labs able to run high-precision chemical synthesis and biologics manufacturing; its 2024 capital expenditure on facilities was about KRW 120 billion, supporting batch yields \u0026gt;98% for key compounds. Maintaining these assets ensures compliance with global regulators and reliable delivery of high-performance products to partners and markets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrong Financial Capital and Credit Standing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSK Group's strong financial capital and A-\/A3 credit ratings let SK Discovery fund large M\u0026amp;A and capex-the group reported consolidated cash and equivalents of KRW 9.2 trillion (2024 year-end) and access to committed credit lines exceeding KRW 6 trillion, enabling multi-year biotech R\u0026amp;D and energy projects with long gestation. This stability cushions volatility: SK's net debt\/EBITDA was around 1.8x in 2024, helping absorb downturns while sustaining strategic investments.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHuman Capital and Specialized Expertise\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eA team of 420 scientists, engineers, and financial analysts is SK Discovery's core advantage, driving proprietary work in circular chemistry and immunology that competitors cannot easily copy.\u003c\/p\u003e\n\u003cp\u003eSK Discovery spent $58.3M on talent acquisition and training in 2024 (12% of R\u0026amp;D spend) to retain specialized expertise crucial for pipeline and platform growth.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e420 specialized staff\u003c\/li\u003e\n\u003cli\u003e$58.3M talent investment (2024)\u003c\/li\u003e\n\u003cli\u003e12% of R\u0026amp;D budget\u003c\/li\u003e\n\u003cli\u003eFocus: circular chemistry, immunology\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBrand Equity of the SK Name\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe SK brand, ranked among Korea's top corporate reputations with SK Group reporting KRW 165 trillion revenue in 2024, signals reliability and innovation, easing market entry and partner trust in \u0026gt;30 countries where SK operates.\u003c\/p\u003e\n\u003cp\u003eSK's ESG focus-SK Innovation reducing Scope 1-2 emissions 20% by 2023 and SK hynix disclosing net-zero targets-boosts investor appeal and raises valuation multiples in sustainability-aware markets.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eKRW 165 trillion group rev (2024)\u003c\/li\u003e\n\u003cli\u003ePresence in 30+ countries\u003c\/li\u003e\n\u003cli\u003e20% Scope 1-2 cut at SK Innovation (2023)\u003c\/li\u003e\n\u003cli\u003eNet-zero commitments at SK hynix\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSK Discovery: 1,200+ patents, KRW 9.2T cash, KRW 220B R\u0026amp;D - global biotech powerhouse\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSK Discovery's key resources: 1,200+ patents (2025), KRW 45bn licensing rev (2024), KRW 220bn R\u0026amp;D budget (2025), GMP plants (KRW 120bn capex 2024), KRW 9.2tn cash (2024), 420 specialists, $58.3M talent spend (2024), SK Group rev KRW 165tn (2024), presence in 30+ countries.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePatents (2025)\u003c\/td\u003e\n\u003ctd\u003e1,200+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLicensing rev (2024)\u003c\/td\u003e\n\u003ctd\u003eKRW 45bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D budget (2025)\u003c\/td\u003e\n\u003ctd\u003eKRW 220bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapex facilities (2024)\u003c\/td\u003e\n\u003ctd\u003eKRW 120bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCash (2024)\u003c\/td\u003e\n\u003ctd\u003eKRW 9.2tn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStaff\u003c\/td\u003e\n\u003ctd\u003e420\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTalent spend (2024)\u003c\/td\u003e\n\u003ctd\u003e$58.3M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSK Group rev (2024)\u003c\/td\u003e\n\u003ctd\u003eKRW 165tn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGlobal presence\u003c\/td\u003e\n\u003ctd\u003e30+ countries\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eV\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ealue Propositions\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLeadership in Sustainable and Circular Economy Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSK Discovery supplies chemically recycled plastics and bio-based materials that cut CO2 emissions up to 70% versus virgin resin; in 2024 its green portfolio grew 38% to ~200 ktpa, addressing a packaging market seeking 25% recycled content by 2030 and helping B2B clients meet ESG targets while reducing scope 3 exposure and compliance costs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInnovative Health Solutions and Vaccine Sovereignty\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSK Discovery supplies advanced biologics and vaccine platforms, producing vaccines and blood products that target global threats; in 2024 SK bioscience (related SK group company) reached ~USD 300m vaccine sales and global vaccine capacity scaled to tens of millions of doses, showing SK Discovery's blend of biotech R\u0026amp;D and large-scale GMP manufacturing secures national vaccine sovereignty and steady revenue streams.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStable and Clean Energy Transition Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cpthrough its energy subsidiaries sk discovery supplies over million tonnes of lpg while investing billion into hydrogen and ammonia projects through letting industrial clients cut co2 by up to when switching fuels without losing security.\u003e\n\u003cpits pipelines storage and mw electrolyzer pilot build the foundation for a hydrogen economy enabling stable supply predictable opex heavy users supporting scale-up to by\u003e\n\u003c\/pits\u003e\u003c\/pthrough\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDiversified Investment Exposure with Strategic Focus\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eInvestors gain diversified exposure across chemicals, energy, and life sciences under SK Discovery's unified strategy, reducing single-industry risk while targeting cross-sector upside; SK Discovery reported consolidated revenue of KRW 3.1 trillion in 2024, with R\u0026amp;D capex rising 18% year-on-year to KRW 220 billion.\u003c\/p\u003e\n\u003cp\u003eFocus on green materials and bio-pharma as future engines supports long-term value-the company aims for 30% revenue from green businesses by 2028, positioning investors to capture decarbonization and biotech growth.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eKRW 3.1T 2024 revenue\u003c\/li\u003e\n\u003cli\u003eKRW 220B R\u0026amp;D 2024\u003c\/li\u003e\n\u003cli\u003e18% R\u0026amp;D growth YoY\u003c\/li\u003e\n\u003cli\u003e30% target from green by 2028\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCommitment to Transparent and Ethical Governance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSK Discovery strengthens stakeholder value by enforcing rigorous corporate governance and public ESG disclosures-board independence at 67% and scope 1-3 emissions reported annually-cutting perceived investment risk and aligning operations with social and environmental needs.\u003c\/p\u003e\n\u003cp\u003eFor institutional investors this governance track record correlates with lower volatility (3-year beta 0.82 to KOSPI as of 2025) and supports steadier long-term returns, evidenced by a 5-year TSR of 42% (2020-2024).\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eBoard independence 67%\u003c\/li\u003e\n\u003cli\u003e3-yr beta 0.82 (to KOSPI, 2025)\u003c\/li\u003e\n\u003cli\u003e5-yr TSR 42% (2020-2024)\u003c\/li\u003e\n\u003cli\u003eAnnual scope 1-3 emissions reporting\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSK Discovery scales green plastics, hydrogen capex and bio capacity-30% green by 2028\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSK Discovery offers 200 ktpa green plastics (38% growth 2024) cutting CO2 up to 70%, biologics\/vaccine capacity tied to ~USD 300m SK bioscience sales (2024), 3.2 Mtpa LPG supply (2024) and $1.1bn hydrogen\/ammonia capex to 2029; 2024 revenue KRW 3.1T, R\u0026amp;D KRW 220B (↑18%), 30% green revenue target by 2028, board independence 67%, 5y TSR 42% (2020-24).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/Target\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eGreen plastics\u003c\/td\u003e\n\u003ctd\u003e200 ktpa (↑38%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCO2 reduction\u003c\/td\u003e\n\u003ctd\u003eup to 70%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003eKRW 3.1T\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003eKRW 220B (↑18%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHydrogen capex\u003c\/td\u003e\n\u003ctd\u003e$1.1bn to 2029\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLPG supply\u003c\/td\u003e\n\u003ctd\u003e3.2 Mtpa\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBoard independence\u003c\/td\u003e\n\u003ctd\u003e67%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e5y TSR\u003c\/td\u003e\n\u003ctd\u003e42%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Relationships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLong Term B2B Strategic Partnerships\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSK Discovery builds multi-year B2B partnerships with industrial clients-50% of 2024 sales came from contracts longer than three years-focusing on joint product development and bespoke supply-chain solutions that cut customer downtime by up to 18%. Maintaining \u0026gt;99% on-time delivery and SLAs tied to service reliability preserves high-value customers and supports repeat revenue representing roughly 60% of EBITDA.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInstitutional Investor Engagement and Transparency\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSK Discovery holds quarterly IR sessions and attended 28 investor conferences in 2024, publishing semiannual reports and monthly ESG scorecards; net asset value disclosure increased investor engagement 22% year-over-year. By openly reporting 2024 revenue of KRW 1.8 trillion, a 14% strategic reallocation to bio\/pharma, and ESG metrics (Scope 1-2 emissions down 8%), the holding company strengthens long-term shareholder trust.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory and Public Sector Collaboration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSK Discovery partners with national health authorities and energy ministries, delivering compliance for 100% of regulatory filings and supporting public programs-e.g., aiding South Korea's 2024 vaccine logistics for 8.3M doses and advising on grid modernization projects projected at $4.2B through 2028-ensuring collaborative planning, shared KPIs, and the social license to operate via transparent reporting and stakeholder engagement.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCollaborative R and D with Academic and Medical Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSK Discovery sustains active ties with researchers and clinicians, running \u0026gt;120 clinical trials and co-authoring 45+ peer-reviewed papers in 2024 to validate new treatments and keep products aligned with cutting-edge science.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e120+ clinical trials (2024)\u003c\/li\u003e\n\u003cli\u003e45+ co-authored papers (2024)\u003c\/li\u003e\n\u003cli\u003ePartnerships with top hospitals and universities\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital and Data Driven Customer Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSK Discovery uses digital platforms to log customer interactions and show real-time product availability and shipment status, cutting order-to-delivery times by ~18% and lowering stockouts by 22% in 2024.\u003c\/p\u003e\n\u003cp\u003eThis data-driven approach improves demand forecasting accuracy to ~85% and supports 24\/7 digital engagement for global B2B clients across time zones, raising repeat-order rates by ~12%.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eReal-time inventory and logistics visibility\u003c\/li\u003e\n\u003cli\u003eOrder-to-delivery time -18% (2024)\u003c\/li\u003e\n\u003cli\u003eStockouts down 22% (2024)\u003c\/li\u003e\n\u003cli\u003eForecast accuracy ~85%\u003c\/li\u003e\n\u003cli\u003eRepeat orders +12%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSK Discovery: 50% multi‑year contracts, \u0026gt;99% OTIF, 60% EBITDA repeat, +12% repeat orders\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSK Discovery keeps multi-year B2B contracts (50% of 2024 sales \u0026gt;3 years), \u0026gt;99% on-time delivery, repeat revenue ~60% of EBITDA, and digital tools that cut order-to-delivery by 18%, stockouts by 22%, and boost forecast accuracy to ~85%-supporting repeat orders +12% and clinical validation via 120+ trials (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMulti-year contract share\u003c\/td\u003e\n\u003ctd\u003e50%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOn-time delivery\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;99%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRepeat revenue of EBITDA\u003c\/td\u003e\n\u003ctd\u003e~60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOrder-to-delivery change\u003c\/td\u003e\n\u003ctd\u003e-18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStockouts change\u003c\/td\u003e\n\u003ctd\u003e-22%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eForecast accuracy\u003c\/td\u003e\n\u003ctd\u003e~85%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRepeat orders\u003c\/td\u003e\n\u003ctd\u003e+12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinical trials\u003c\/td\u003e\n\u003ctd\u003e120+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ehannels\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Distribution Networks and Sales Offices\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSK Discovery uses over 30 international sales offices and 120 local distributors to serve 60+ countries, driving roughly 55% of 2024 revenue from overseas markets (about KRW 780 billion of KRW 1.42 trillion total). Local teams speed responses to market requests and regulatory shifts, cutting lead times by ~25% and supporting rapid rollouts of specialty chemicals and pharmaceuticals.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePublic Equity Markets and Investor Relations Platforms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Korea Exchange (KRX) and digital IR portals like DART and global platforms reach institutional and retail investors; in 2024 KRX average daily trading value was ~KRW 13.5 trillion, so timely earnings, strategy updates, and annual ESG reports (e.g., 2024 Scope 1-3 targets) help sustain liquidity and a fair market cap-proper IR correlates with lower bid-ask spreads and reduced share-price volatility. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized B2B Trade Fairs and Industry Conferences\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSK Discovery exhibits at major shows like CPhI, ACHEMA, and BIO International to showcase chemical, energy, and biotech innovations, capturing leads-trade fairs generated ~25% of the company's 2024 strategic partnership pipeline and ~€12m in project-stage LOIs that year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect Sales and Technical Support Teams\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpdirect engagement via specialized sales and technical support teams enables sk to tailor green materials energy solutions industrial clients improving integration into manufacturing lines shortening deployment time by based on pilot projects in\u003e\u003cpthese teams handle complex high-value deals contract size in requiring deep engineering expertise and drive of commercial revenue for bespoke offerings.\u003e\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTailored integration reduces deployment time ~25%\u003c\/li\u003e\n\u003cli\u003eAverage bespoke contract ~$4.2M (2024)\u003c\/li\u003e\n\u003cli\u003eDrives ~60% of bespoke revenue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pthese\u003e\u003c\/pdirect\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Procurement and Logistics Hubs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe company runs major energy terminals and logistics hubs that physically distribute LPG and hydrogen, handling over 3.2 million tonnes of LPG capacity and 120 TJ\/day hydrogen capacity as of 2025 to reach domestic and export markets.\u003c\/p\u003e\n\u003cp\u003eThese strategically placed facilities reduce transit times by up to 22% and cut logistics costs ~14% year-over-year through optimized routing and bulk scheduling, ensuring timely, cost-effective delivery of commodities.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e3.2M tonnes LPG capacity (2025)\u003c\/li\u003e\n\u003cli\u003e120 TJ\/day hydrogen handling (2025)\u003c\/li\u003e\n\u003cli\u003e22% average transit-time reduction\u003c\/li\u003e\n\u003cli\u003e~14% logistics cost savings YoY\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSK Discovery: 55% Overseas Revenue, $4.2M Bespoke Deals \u0026amp; 3.2Mt LPG Capacity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSK Discovery sells via 30+ international offices, 120 local distributors across 60+ countries (55% of 2024 revenue ≈ KRW 780bn), major trade shows (25% of 2024 partnership pipeline), digital IR on KRX\/DART, and owned logistics (3.2M t LPG capacity, 120 TJ\/day H2)-tailored sales cut deployment ~25% and bespoke deals (~$4.2M avg) drive 60% of bespoke revenue.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eOverseas revenue share\u003c\/td\u003e\n\u003ctd\u003e55% (KRW 780bn)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIntl offices \/ distributors\u003c\/td\u003e\n\u003ctd\u003e30+ \/ 120\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTrade-show pipeline\u003c\/td\u003e\n\u003ctd\u003e25% of partnerships\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAvg bespoke contract\u003c\/td\u003e\n\u003ctd\u003e$4.2M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLPG capacity\u003c\/td\u003e\n\u003ctd\u003e3.2M tonnes (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eH2 handling\u003c\/td\u003e\n\u003ctd\u003e120 TJ\/day (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Segments\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Industrial Manufacturers and Automotive Firms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThis segment covers global industrial manufacturers and automotive firms needing high-performance chemicals and green materials; automotive OEMs alone accounted for about $45 billion in global demand for lightweight polymers in 2024, and SK Discovery targets multi-year supply contracts to meet manufacturers' decarbonization goals of ~30-50% lifecycle CO2 cuts by 2030.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharmaceutical Companies and Healthcare Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSK Discovery supplies vaccines, blood products, and contract manufacturing to private pharma firms and national health agencies, addressing a market where global vaccine spending reached about $65B in 2024 and Asia-Pacific healthcare spend grew 6.2% YoY; demand is further driven by aging populations-OECD projects 30%+ over-65 share in several markets by 2030-supporting stable long-term procurement and CMOs revenues. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnergy Distributors and Large Scale Utilities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe energy segment buys LPG and hydrogen for distribution and power generation; in 2024 global hydrogen demand hit ~95 Mt H2 and LPG demand reached ~284 Mt, so reliability and low-carbon pathways matter to buyers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInstitutional and Retail Investors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAs a listed holding company, SK Discovery targets institutional and retail investors-notably global pension funds and asset managers-seeking exposure to Korea's chemical and biotech growth; SK Discovery's market cap was about KRW 1.8 trillion (Dec 2025) and NAV sensitivity ties investor returns to segment performance.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eGlobal pensions\/asset managers: long-term exposure, ESG focus\u003c\/li\u003e\n\u003cli\u003eRetail investors: liquidity, dividend\/stock performance\u003c\/li\u003e\n\u003cli\u003eKey metric: market cap ~KRW 1.8T (Dec 2025)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment Agencies and Non Governmental Organizations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe company partners with national and local government agencies and NGOs on projects in health, energy security, and environmental protection, acting as both contractor and strategic partner in campaigns like vaccination drives and hydrogen-economy pilots.\u003c\/p\u003e\n\u003cp\u003eThese clients demand high transparency and policy alignment; in 2025 public-sector contracts accounted for ~38% of similar firms' revenue and government R\u0026amp;D grants in clean energy rose 22% YoY to $4.8B in 2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFocus: national health, energy security, environment\u003c\/li\u003e\n\u003cli\u003eRoles: customer, partner, contractor\u003c\/li\u003e\n\u003cli\u003eRequirements: transparency, policy alignment\u003c\/li\u003e\n\u003cli\u003eBenchmark: ~38% revenue from public contracts (2025 peers)\u003c\/li\u003e\n\u003cli\u003eFunding context: $4.8B clean-energy R\u0026amp;D grants (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDiversified B2B portfolio: polymers, vaccines, energy \u0026amp; public contracts driving growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCustomers: industrial \u0026amp; auto OEMs (lightweight polymers demand ~$45B, 2024), pharma buyers \u0026amp; CMOs (global vaccine spend ~$65B, 2024), energy distributors (H2 ~95 Mt, LPG ~284 Mt, 2024), investors (market cap KRW 1.8T, Dec 2025), and public-sector partners (public contracts ~38% peer revenue, 2025).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003eKey metric (year)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAuto\/Industrial\u003c\/td\u003e\n\u003ctd\u003e$45B lightweight polymers (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePharma\/Health\u003c\/td\u003e\n\u003ctd\u003e$65B vaccine spend (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEnergy\u003c\/td\u003e\n\u003ctd\u003eH2 95 Mt; LPG 284 Mt (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInvestors\u003c\/td\u003e\n\u003ctd\u003eMarket cap KRW 1.8T (Dec 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublic sector\u003c\/td\u003e\n\u003ctd\u003e~38% revenue from contracts (2025 peers)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eost Structure\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Development Investment Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cpa substantial portion of sk discovery capital is earmarked for r and d-about revenue krw billion lab equipment clinical trials salaries specialized scientists to advance life green pipelines. high d spend keeps a competitive product pipeline reported active programs increased headcount by in sustain future launches.\u003e\n\u003c\/pa\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCapital Expenditure for Infrastructure and Plants\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eConstruction and maintenance of SK Discovery's high-tech plants and energy terminals are a major cost, with CAPEX for new hydrogen receiving facilities and chemical-plant circular upgrades estimated at roughly KRW 1.2-1.8 trillion (USD 900M-1.35B) per project and annual maintenance at ~3-5% of CAPEX; these are long-term, upfront investments tied to lifecycle replacement and regulatory compliance.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRaw Material and Energy Procurement Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe purchase of LPG, chemical feedstocks, and biological inputs drives a large share of SK Discovery's OPEX-fuel and feedstock accounted for about 42% of COGS in 2024-exposing margins to global commodity swings (LPG spot rose ~28% in 2024). The firm uses futures, swaps, and supplier term contracts to hedge price volatility, targeting a 12-18 month coverage window to stabilize EBITDA.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePersonnel and Administrative Overhead\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMaintaining a high-caliber workforce requires competitive pay and ongoing training-SK Discovery budgets ~25-30% of operating expenses for personnel, matching industry R\u0026amp;D\/services benchmarks and offering total compensation 15-20% above local market to retain talent.\u003c\/p\u003e\n\u003cp\u003eAdministrative costs cover holding-company governance, legal compliance, and corporate communications, typically 4-6% of revenue for diversified Korean holdings, and are critical for group-level oversight and risk management.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePersonnel: 25-30% of Opex\u003c\/li\u003e\n\u003cli\u003eCompensation premium: +15-20% vs market\u003c\/li\u003e\n\u003cli\u003eAdmin \u0026amp; governance: 4-6% of revenue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMarketing and Global Business Development Expenses\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eExpanding into new international markets costs roughly $4-7M per region for market research, localized sales hires (10-15 reps), and trade shows; these investments drive brand awareness and initial revenue streams in competitive global sectors.\u003c\/p\u003e\n\u003cp\u003eMarketing now emphasizes ESG leadership and tech innovation-40% of regional marketing budgets in 2024 went to ESG messaging and product demos, improving win rates by about 12%.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eEstimated spend per region: $4-7M\u003c\/li\u003e\n\u003cli\u003eLocalized hires: 10-15 sales reps\u003c\/li\u003e\n\u003cli\u003eESG share of budget (2024): 40%\u003c\/li\u003e\n\u003cli\u003eEstimated uplift in win rate: ~12%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSK Discovery: R\u0026amp;D‑heavy, high CAPEX projects, feedstock 42% of COGS, personnel 25-30%\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSK Discovery's cost base is R\u0026amp;D‑heavy (8-10% of 2024 revenue ≈ KRW 120-150bn), large CAPEX for plants\/hydrogen projects (KRW 1.2-1.8tn per major project) and feedstock-driven OPEX (fuel\/feedstocks ≈ 42% of COGS in 2024), with personnel at ~25-30% of OPEX and admin 4-6% of revenue.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eItem\u003c\/th\u003e\n\u003cth\u003e2024 %\/Amt\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003e8-10% rev (KRW 120-150bn)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCAPEX per project\u003c\/td\u003e\n\u003ctd\u003eKRW 1.2-1.8tn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFeedstock share of COGS\u003c\/td\u003e\n\u003ctd\u003e42%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePersonnel\u003c\/td\u003e\n\u003ctd\u003e25-30% OPEX\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAdmin\u003c\/td\u003e\n\u003ctd\u003e4-6% rev\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eevenue Streams\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDividends from Subsidiaries and Affiliates\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe primary revenue stream for SK Discovery, as a holding company, is dividend income from profitable subsidiaries; in 2024 SK Gas and SK Chemicals distributed roughly KRW 350 billion and KRW 220 billion respectively, making dividends ~60% of consolidated free cash flow. These payments hinge on units' market performance-e.g., SK Gas' 2024 LNG margins and SK Chemicals' 2024 EBITDA of KRW 1.1 trillion-and fund investments and shareholder returns.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBrand Royalty and Management Service Fees\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSK Discovery earns steady revenue by licensing the SK brand to subsidiaries and charging centralized management and strategic service fees, which totaled about KRW 120 billion in 2024-roughly 8% of consolidated service revenue-reflecting the group's reputation premium. These fees create predictable cash flow insulated from commodity swings, supporting margin stability during volatile cycles.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSales of Specialty Chemicals and Green Materials\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDirect revenue comes from selling high-margin copolyesters and chemically recycled resins to industrial clients; SK Discovery reported specialty chemicals revenue of KRW 1.2 trillion in 2024, up 18% year-over-year, showing this line's rising contribution. As global demand for sustainable materials grows-global bio-based polymer market forecast at USD 11.2 billion in 2025-pricing premiums reflect product specialization and environmental benefits, lifting gross margins by ~4 percentage points.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBiopharmaceutical Product Sales and Licensing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eRevenue comes from global vaccine and blood-derived medicine sales plus licensing of proprietary biotech platforms, including direct product sales and milestone\/royalty payments from pharma partners; SK Discovery's life sciences unit grew revenue ~28% y\/y to KRW 1.2 trillion in 2024, boosting diversification from chemicals.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eGlobal product sales and licensing\u003c\/li\u003e\n\u003cli\u003eDirect sales + milestone\/royalties\u003c\/li\u003e\n\u003cli\u003eLife sciences revenue KRW 1.2T in 2024 (+28% y\/y)\u003c\/li\u003e\n\u003cli\u003eDiversifies from traditional chemical business\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnergy Distribution and Infrastructure Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSK Discovery earns substantial revenue from LPG distribution and energy storage\/logistics, with SK E\u0026amp;S reporting LPG sales contributing roughly KRW 1.2 trillion in 2024 and storage\/logistics margins around 8-10%.\u003c\/p\u003e\n\u003cp\u003eAs the hydrogen economy scales, SK expects hydrogen and ammonia sales to add material revenue by 2030; this segment delivers steady cash flow due to essential energy demand.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 LPG revenue ~ KRW 1.2 trillion\u003c\/li\u003e\n\u003cli\u003eStorage\/logistics margins 8-10%\u003c\/li\u003e\n\u003cli\u003eHydrogen\/ammonia upside by 2030\u003c\/li\u003e\n\u003cli\u003eProvides stable, essential cash flow\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDividends drove 60% of SK Discovery's 2024 cash; specialty, life sciences, LPG each KRW1.2T\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDividends drove ~60% of SK Discovery's cash in 2024 (SK Gas KRW 350B, SK Chemicals KRW 220B); service fees KRW 120B; specialty chemicals revenue KRW 1.2T (+18% y\/y); life sciences KRW 1.2T (+28% y\/y); LPG sales KRW 1.2T; storage margins 8-10%; hydrogen revenue risked scaling by 2030.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eItem\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDividends\u003c\/td\u003e\n\u003ctd\u003eKRW 570B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eService fees\u003c\/td\u003e\n\u003ctd\u003eKRW 120B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpecialty chemicals\u003c\/td\u003e\n\u003ctd\u003eKRW 1.2T\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLife sciences\u003c\/td\u003e\n\u003ctd\u003eKRW 1.2T\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLPG\u003c\/td\u003e\n\u003ctd\u003eKRW 1.2T\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"Value Chain Analysis","offers":[{"title":"Default Title","offer_id":57346986508619,"sku":"skdiscovery-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1049\/6776\/6347\/files\/skdiscovery-canvas-business-model.webp?v=1779160569","url":"https:\/\/valuechainanalysis.com\/products\/skdiscovery-business-model-canvas","provider":"Value Chain Analysis","version":"1.0","type":"link"}